The cancer and fibrosis drug developer's series D round was co-led by investors including Walvax Biotechnology and a fund management vehicle for Sunshine Insurance.

Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.

Google has reportedly supplied the funding as part of a larger round with a $7.5bn pre-money valuation that the online marketplace aims to close at $1bn.

The managed cybersecurity demand and response services provider boosted its valuation to $1.3bn in a series E round backed by Deutsche Telekom subsidiary DTCP.

Sarepta Therapeutics provided $15m in a series A round for the startup, which is working on genetic medicines for rare diseases.

Airbus Ventures participated in a series C round that boosted the car dealership software provider's total funding to $215m in four years.

The UnitedHealthcare-backed health insurer has announced a $105m series B round that comes after a $70m round two years ago.

Existing investor Cox Enterprises led a debt and equity round to increase its share in the indoor farm operator to a majority stake.

The diagnostics technology developer picked up Jemincare and Haier Biomedical for its second funding round since spinning off from parent company 3D Medicines in 2018.

Softbank China and Sinopharm-CICC Capital returned for a series B-plus round after backing the online pharmacy's 2019 series B.